Depo-Provera lawsuit lawyers are helping thousands of women seek compensation for meningioma brain tumors linked to this popular birth control shot. If you used Depo-Provera and later received a meningioma diagnosis, 2026 could be a turning point for your case.
The litigation against Pfizer has grown rapidly. Over 700 lawsuits were consolidated into a federal MDL by late 2024. Bellwether trials are now being scheduled, and settlement talks could follow.
This guide covers everything you need to know. You will learn who qualifies, what lawyers charge, how much settlements might be worth, and what evidence you need to build a strong claim.
One fact stands out: a 2024 BMJ study found that women who used Depo-Provera for three or more years had a nearly sixfold increased risk of developing intracranial meningiomas. That statistic is driving this entire wave of litigation.
Depo-Provera Lawsuit Lawyers
Depo-Provera lawsuit lawyers are attorneys who specialize in representing women harmed by the birth control injection. These lawyers typically work within mass tort and product liability law. They handle cases against Pfizer, the manufacturer of Depo-Provera.
Finding the right attorney matters more than most people realize. Not every personal injury lawyer has the experience or resources to take on a pharmaceutical giant. Mass tort cases require specific expertise in medical causation, FDA regulations, and multidistrict litigation procedures.
The best firms handling these cases have already signed up hundreds of clients. They work on contingency, meaning you pay nothing unless your case results in compensation. Think of it like hiring a contractor who only gets paid when the house is built.
| What to Look For | Why It Matters |
|---|---|
| Mass tort experience | Pfizer cases require large-scale litigation knowledge |
| Medical expert access | Proving causation needs expert testimony |
| Contingency fee structure | No upfront cost to you |
| Track record with pharma cases | Shows ability to go against major corporations |
| Dedicated case team | Your case gets consistent attention |
Most of these attorneys offer free case evaluations. That first call typically lasts 15 to 30 minutes. During that time, they will ask about your Depo-Provera usage history and your medical diagnosis.
Depo-Provera Meningioma Lawsuit
The Depo-Provera meningioma lawsuit centers on one core allegation: Pfizer knew or should have known that its contraceptive injection increased the risk of meningioma brain tumors but failed to warn patients adequately. This litigation has grown into one of the largest pharmaceutical mass torts active in 2026.
Meningiomas are tumors that form in the meninges, the protective membranes surrounding the brain and spinal cord. While they are typically classified as benign, “benign” is misleading. These tumors can cause seizures, vision loss, cognitive decline, and require invasive surgery.
Plaintiffs argue that Depo-Provera’s active ingredient, medroxyprogesterone acetate, is a synthetic progestin that stimulates progesterone receptors found in meningioma cells. The scientific connection has been documented in peer-reviewed research going back over a decade.
A landmark 2024 study published in the BMJ analyzed over 100,000 women. It found a 5.6 times higher risk of meningioma among long-term Depo-Provera users. France’s health agency had already restricted prolonged use based on earlier data.
- Pfizer is the primary defendant in these lawsuits
- The Upjohn Company, which originally developed the drug, is also named in some complaints
- Cases allege failure to warn, design defect, and negligent misrepresentation
- Most plaintiffs are women who used the injection for one year or longer
This is not a situation where the science is ambiguous. The data is strong, and the legal claims are built on it.
Depo-Provera Lawsuit Update 2026
As of 2026, the Depo-Provera litigation is entering a critical phase. The MDL has been consolidated in the U.S. District Court for the Northern District of Alabama under Judge Madeline Hughes Haikala. Case filings continue to increase each month.
The court has been working through the discovery phase. Pfizer has been ordered to produce internal documents related to what it knew about meningioma risks and when it knew it. This discovery process is expected to reveal key evidence.
Bellwether trial selection is underway. These test cases will likely go to trial in late 2026 or early 2027. The outcomes of bellwether trials set the stage for potential global settlement negotiations.
| 2026 Milestone | Expected Timing |
|---|---|
| Discovery completion | Mid-2026 |
| Bellwether case selection finalized | Q2 2026 |
| First bellwether trial | Late 2026 to early 2027 |
| Potential settlement talks | Following bellwether verdicts |
| New case filing activity | Ongoing throughout 2026 |
Several state court cases are also progressing independently. Some plaintiffs have filed in state courts in California, New Jersey, and Pennsylvania. These cases may move faster than the federal MDL.
The pace of new filings suggests this litigation is still growing. Legal experts estimate the total number of cases could exceed several thousand by the end of 2026.
Key Takeaway: The Depo-Provera litigation is hitting major milestones in 2026, with bellwether trials on the horizon and the potential for settlement discussions to begin after initial verdicts.
Depo-Provera Lawsuit Settlement Amounts
No Depo-Provera settlements have been finalized yet in 2026. That said, legal analysts and mass tort attorneys have projected potential settlement ranges based on the severity of injuries and comparable pharmaceutical litigation.
Settlement values in mass tort cases depend on several factors. The type and grade of meningioma, whether surgery was needed, the duration of Depo-Provera use, and the long-term impact on quality of life all play a role.
Based on projections from experienced mass tort firms, here is what potential payouts could look like:
| Case Tier | Injury Level | Estimated Settlement Range |
|---|---|---|
| Tier 1 (Highest) | Surgery, permanent neurological damage | $300,000 to $1,500,000+ |
| Tier 2 (Moderate) | Surgery, partial recovery | $100,000 to $300,000 |
| Tier 3 (Lower) | Diagnosed meningioma, monitored without surgery | $25,000 to $100,000 |
These are projections, not guarantees. Actual amounts will depend on bellwether trial outcomes and Pfizer’s willingness to negotiate. In similar pharmaceutical cases like the Zantac and talcum powder litigation, settlements ranged widely based on case strength.
One thing to keep in mind: the stronger your medical documentation and usage records, the higher your potential compensation. Cases with clear, long-term Depo-Provera use and confirmed meningioma diagnosis through MRI or biopsy will command the highest values.
Women who underwent craniotomy or other brain surgery tend to have the most valuable claims. The physical, emotional, and financial toll of brain surgery is significant. Juries and settlement negotiators take that seriously.
Who Qualifies for the Depo-Provera Lawsuit
You may qualify for the Depo-Provera lawsuit if you received Depo-Provera injections and were later diagnosed with a meningioma brain tumor. That is the fundamental requirement that every attorney will evaluate first.
The eligibility criteria go deeper than that basic threshold, though. Here is what lawyers are looking for when they review potential cases:
- You received at least one Depo-Provera injection (though longer use strengthens the case)
- You were diagnosed with a meningioma at any point after starting the injections
- You have medical records confirming the diagnosis (MRI, CT scan, or biopsy results)
- You have pharmacy records, medical charts, or doctor’s notes confirming Depo-Provera use
Certain factors make a case stronger. Women who used the drug for two years or more have a much more compelling claim. Those diagnosed with multiple meningiomas or who required surgery are in an even stronger position.
| Qualification Factor | Impact on Case Strength |
|---|---|
| Duration of use (3+ years) | Very strong |
| Duration of use (1 to 2 years) | Moderate |
| Single injection only | Weaker but still possible |
| Surgery required | Increases case value significantly |
| Ongoing neurological effects | Increases case value significantly |
| Meningioma diagnosed post-use | Essential requirement |
Family members of women who passed away from complications related to meningioma may also qualify to file wrongful death claims. These cases carry additional complexities but are being accepted by several firms.
If you are unsure whether you qualify, the fastest way to find out is to contact a mass tort attorney for a free evaluation. They can review your medical and usage history in a single consultation.
Depo-Provera Brain Tumor Lawsuit
The Depo-Provera brain tumor lawsuit specifically targets the connection between the contraceptive shot and the development of meningiomas. These are the most common type of primary brain tumor in adults, and research increasingly points to hormonal contraceptives as a risk factor.
Here is why this matters: meningiomas grow slowly, and many women do not discover them until years or even decades after they stop using Depo-Provera. By the time symptoms appear, the tumor may already be large enough to require surgery.
The science behind these claims is built on multiple studies. The BMJ study from 2024 is the most cited, but earlier research from French institutions and the World Health Organization also flagged the risk. The WHO classified medroxyprogesterone acetate as having a plausible biological mechanism for tumor growth.
- Progesterone receptors are present in approximately 70% of meningiomas
- Depo-Provera delivers a high-dose synthetic progestin directly into the body
- The drug maintains elevated progestin levels for three months per injection
- Prolonged exposure creates sustained stimulation of tumor-prone tissue
Brain tumor cases are among the most serious in all of mass tort law. The injuries are life-altering. Surgery carries real risks, including infection, cognitive changes, and nerve damage. Recovery can take months or years.
That severity is exactly why projected settlement values for these cases are higher than many other pharmaceutical lawsuits.
Key Takeaway: The scientific link between Depo-Provera and brain tumors is well-established in peer-reviewed research, giving plaintiffs a strong foundation for their claims in 2026.
How to File a Depo-Provera Lawsuit
Filing a Depo-Provera lawsuit starts with contacting a qualified mass tort attorney who is actively accepting these cases. The process is straightforward for most claimants and does not require you to pay anything upfront.
Here is the step-by-step process:
Step 1: Free Case Evaluation
Call or submit an inquiry to a law firm handling Depo-Provera cases. They will ask basic questions about your drug use and medical history.
Step 2: Medical Records Review
The attorney’s team will request your medical records to verify your meningioma diagnosis and Depo-Provera usage.
Step 3: Sign a Retainer Agreement
If your case qualifies, you will sign a contingency fee agreement. This means the firm only gets paid if you win or settle.
Step 4: Case Filing
Your attorney files your complaint in federal court (the MDL in Alabama) or in an appropriate state court.
Step 5: Discovery and Litigation
Your case joins the broader litigation. You may be asked to provide a deposition or additional records, but most day-to-day litigation work is handled by your legal team.
| Filing Step | What You Do | What Your Lawyer Does |
|---|---|---|
| Initial contact | Share your story | Evaluate your claim |
| Records gathering | Authorize record release | Obtain and review medical records |
| Signing agreement | Review and sign | Explain fee structure and process |
| Case filing | Nothing required from you | Prepare and file the complaint |
| Ongoing litigation | Respond to occasional requests | Handle all court proceedings |
The entire intake process typically takes two to four weeks. After that, your case enters the litigation queue. You do not need to appear in court during the early phases.
Depo-Provera Lawsuit Eligibility
Depo-Provera lawsuit eligibility is determined by two primary factors: confirmed use of the drug and a subsequent meningioma diagnosis. Without both of these elements, most firms will not accept a case.
Let’s break eligibility down more specifically. The “confirmed use” requirement means you need some form of documentation. Pharmacy records are ideal. Medical charts noting the injection are also accepted. Even prescription history from an insurance provider can work.
The diagnosis requirement is equally important. An MRI or CT scan showing a meningioma is the most common form of proof. Surgical pathology reports carry even more weight. If you were monitored for a suspected meningioma but never formally diagnosed, your case may still be worth evaluating.
Some situations create eligibility questions:
- Used Depo-Provera decades ago: Still eligible if diagnosed with meningioma at any point after use
- Used it for only a few months: Cases are weaker but not automatically disqualified
- Diagnosed with a different type of brain tumor: Generally not eligible unless it is a meningioma subtype
- Used generic medroxyprogesterone acetate: May still qualify depending on the manufacturer
The bottom line is that if you have a meningioma and a history of Depo-Provera use, you should speak with an attorney. Even borderline cases deserve a professional review. Many women do not realize they qualify until they have that first conversation.
Depo-Provera Class Action Lawsuit
The Depo-Provera litigation is not technically a class action lawsuit. It is a mass tort consolidated into a multidistrict litigation, or MDL. This is a common point of confusion, and the distinction matters.
In a class action, one group of plaintiffs files on behalf of everyone who was affected. Everyone gets the same payout. In an MDL, each plaintiff files their own individual case. Your settlement or verdict is based on your specific injuries and circumstances.
This is actually better for most Depo-Provera plaintiffs. A woman who had brain surgery and suffers permanent cognitive damage should not receive the same compensation as someone whose meningioma was caught early and monitored without intervention. The MDL structure allows for individualized awards.
| Feature | Class Action | Mass Tort (MDL) |
|---|---|---|
| Individual case filing | No | Yes |
| Compensation based on personal injury | No | Yes |
| One payout for everyone | Yes | No |
| Centralized pretrial proceedings | Sometimes | Yes |
| Bellwether trials | Rare | Common |
| Opt-out option | Yes | Not applicable (individual cases) |
Think of it this way: a class action is like everyone splitting one pizza. An MDL is like everyone ordering their own meal based on what they need. The MDL approach gives you more control over your case and its value.
All federal Depo-Provera cases are centralized in the Northern District of Alabama. State court cases remain in their respective jurisdictions.
Key Takeaway: Depo-Provera lawsuits are filed as individual claims within an MDL, not as a class action, meaning your compensation will reflect your specific injuries and medical history.
Depo-Provera MDL Status
The Depo-Provera MDL was established in 2024 when the Judicial Panel on Multidistrict Litigation consolidated federal cases into one court. The MDL is housed in the U.S. District Court for the Northern District of Alabama, with Judge Madeline Hughes Haikala presiding.
As of early 2026, the MDL has been progressing through several key phases. Initial case management orders have been issued. Discovery is ongoing, with Pfizer producing internal documents about its knowledge of meningioma risks.
The MDL structure allows hundreds or thousands of individual cases to share pretrial work. This includes document discovery, expert witness preparation, and depositions of Pfizer employees and scientists. The efficiency saves time and money for everyone involved.
Key MDL numbers to know:
- MDL No. 3127 is the official case designation
- Over 700 cases had been filed as of late 2024, with the number growing steadily
- Lead plaintiffs’ counsel has been appointed to coordinate strategy
- A Plaintiffs’ Steering Committee manages day-to-day litigation tasks
The MDL process is designed to push toward resolution, either through settlement or trial. If bellwether trials in late 2026 or early 2027 produce plaintiff verdicts, that typically accelerates settlement negotiations. Pfizer would face the prospect of thousands of individual trials, which is a powerful motivator to negotiate.
For individual plaintiffs, being part of the MDL means your case benefits from the collective resources of the entire litigation. You do not bear the cost of fighting Pfizer alone.
Depo-Provera Bellwether Trials
Bellwether trials are test cases selected from the larger MDL to go to trial first. In the Depo-Provera litigation, these trials will likely begin in late 2026 or early 2027. They serve as a preview of how juries might respond to the evidence.
The selection process for bellwether cases is methodical. Both sides, plaintiffs and Pfizer, have input. Cases are chosen to represent a range of injury types and circumstances. Some may involve severe surgical outcomes, while others might feature monitoring-only cases.
Here is why bellwether trials matter so much:
- They test the strength of the scientific evidence in front of a real jury
- They reveal how Pfizer’s defense arguments hold up under cross-examination
- Verdicts create precedent that influences settlement negotiations
- Large plaintiff verdicts pressure defendants to settle remaining cases
- Defense verdicts can weaken the plaintiff pool or slow momentum
| Bellwether Phase | Expected Timeline |
|---|---|
| Case pool identification | Early to mid-2026 |
| Final bellwether selection | Mid-2026 |
| Pretrial preparation | Q3 2026 |
| First trial(s) | Late 2026 to Q1 2027 |
| Post-trial settlement talks | 2027 |
It is similar to how a pilot episode works for a TV series. The network tests one episode before committing to the full season. A bellwether trial tests one case before both sides decide whether to settle the rest.
If plaintiffs win significant verdicts, expect Pfizer to come to the negotiating table. If Pfizer wins, the litigation could slow, but it rarely stops entirely.
Depo-Provera Side Effects Lawsuit
The broader Depo-Provera side effects lawsuit focuses primarily on meningioma, but the drug has a long history of other serious side effects that contribute to the overall legal picture. These additional side effects help establish a pattern of risk that Pfizer allegedly downplayed.
Known side effects of Depo-Provera include:
- Bone density loss (FDA added a black box warning in 2004)
- Irregular bleeding and amenorrhea
- Weight gain (average of 5 to 10 pounds in the first year)
- Depression and mood changes
- Decreased libido
- Delayed return of fertility (up to 18 months after stopping)
- Meningioma brain tumors (the focus of current litigation)
The meningioma risk was not added to the U.S. label until after significant litigation pressure. France restricted prolonged Depo-Provera use in 2022 after their health agency found elevated meningioma risk. The FDA has been slower to act.
Lawsuits argue that Pfizer had a duty to warn patients about all known risks. The failure to adequately warn about meningioma risk specifically forms the basis of most claims. Plaintiffs say they would have chosen a different contraceptive method if they had known the full picture.
The fact that Pfizer already had a black box warning for bone loss shows the company was aware its product carried serious risks. The argument is that meningioma should have received similar attention much earlier.
Key Takeaway: While meningioma is the central injury in current lawsuits, Pfizer’s history of inadequate warnings about other serious side effects strengthens the overall case against the company.
Depo-Provera Meningioma Symptoms
Depo-Provera meningioma symptoms often develop gradually, making them easy to dismiss or attribute to other conditions. Many women live with a growing meningioma for years before receiving a diagnosis. Knowing the warning signs is essential for anyone who has used the drug.
Common symptoms of meningioma include:
- Persistent headaches that worsen over time
- Vision changes, including blurred or double vision
- Hearing loss or ringing in the ears
- Memory problems or difficulty concentrating
- Weakness in arms or legs
- Seizures (in more advanced cases)
- Personality or behavioral changes
- Loss of smell
The specific symptoms depend on where the tumor is located. A meningioma near the frontal lobe might cause personality changes. One near the optic nerve can affect vision. Tumors near the base of the skull may impact hearing and balance.
| Tumor Location | Common Symptoms |
|---|---|
| Frontal lobe | Personality changes, difficulty thinking |
| Parietal area | Weakness, numbness, seizures |
| Near optic nerve | Vision loss, double vision |
| Base of skull | Hearing changes, facial numbness |
| Spinal cord | Back pain, weakness in limbs |
If you used Depo-Provera and experience any of these symptoms, talk to your doctor about getting an MRI. Early detection matters for both your health and your legal options. A documented diagnosis is the foundation of any lawsuit.
Many women report that their symptoms were initially dismissed as stress, migraines, or aging. Advocacy groups are pushing for better screening protocols for long-term Depo-Provera users.
Best Lawyers for Depo-Provera Lawsuit
The best lawyers for a Depo-Provera lawsuit are mass tort attorneys with a proven history of taking on pharmaceutical companies. Not every injury attorney is equipped for this kind of fight. You need someone who understands MDL procedures, medical science, and how to build a product liability case against a corporation like Pfizer.
Here is what separates the top firms from the average ones:
- Prior pharmaceutical litigation experience (think talcum powder, Zantac, Roundup)
- Financial resources to fund expensive discovery and expert witnesses
- Medical expert networks to establish causation between Depo-Provera and meningioma
- A seat at the table in the MDL or Plaintiffs’ Steering Committee
- Clear communication with clients about case status and expectations
| Quality | Why It Matters |
|---|---|
| MDL involvement | Firms on the Plaintiffs’ Steering Committee drive strategy |
| Case volume | Handling hundreds of cases shows dedication to this litigation |
| Transparent fee structure | You should know exactly what percentage they take |
| Client reviews | Past client experiences reveal how the firm treats people |
| No pressure tactics | Good firms inform; they do not hard-sell |
When evaluating firms, ask direct questions. How many Depo-Provera cases do you currently handle? What is your contingency fee percentage? Will I work with a dedicated attorney or a paralegal? Have you been involved in the MDL proceedings?
The right attorney makes a significant difference in the outcome of your case. Take time to research before signing with the first firm you find. A 30-minute consultation can tell you a lot about whether a firm is the right fit.
Depo-Provera Lawyer Fees
Depo-Provera lawyer fees are structured on a contingency basis in virtually all mass tort cases. This means you do not pay any money upfront. Your attorney gets a percentage of your settlement or verdict, and only if your case is successful.
The standard contingency fee range for mass tort cases is 25% to 40% of the total recovery. Most Depo-Provera firms are charging between 33% and 40%. Some firms may offer lower percentages for cases that settle early without going to trial.
| Fee Structure | Details |
|---|---|
| Contingency percentage | 25% to 40% of total recovery |
| Upfront cost to you | $0 |
| Case expenses (costs) | Usually advanced by the firm and deducted from settlement |
| If you lose | You owe nothing |
| Retainer required | Typically no |
There are a couple of things to watch for. Some firms deduct case expenses (filing fees, medical record costs, expert witness fees) before calculating their percentage. Others take their percentage first, then deduct costs. This difference can affect your take-home amount by thousands of dollars.
Ask for a written breakdown of how fees and costs are calculated. A reputable firm will explain this clearly. If a firm is vague about their fee structure, that is a red flag.
Here is a practical example. If your case settles for $200,000 and your attorney charges 33%, their fee is $66,000. If case costs total $5,000, your net would be approximately $129,000. Always get these numbers in writing before you sign anything.
Key Takeaway: Depo-Provera lawyers work on contingency, so you pay nothing unless you win, but understanding fee percentages and cost deductions can mean a difference of thousands of dollars in your final payout.
Depo-Provera Lawsuit Evidence Needed
The evidence needed for a Depo-Provera lawsuit falls into two categories: proof of drug use and proof of injury. Without solid documentation in both areas, your case will struggle, no matter how strong the science is.
Proof of Depo-Provera use:
- Pharmacy records showing injection dates
- Medical charts or doctor’s notes documenting the prescription
- Insurance claim history for the injections
- Personal records (receipts, calendars, journal entries)
- Testimony from a prescribing physician
Proof of meningioma diagnosis:
- MRI or CT scan reports showing the tumor
- Surgical pathology reports (if surgery was performed)
- Neurology or neurosurgery consultation notes
- Biopsy results confirming meningioma type and grade
- Follow-up imaging showing tumor progression or recurrence
| Evidence Type | Strength Level | Where to Get It |
|---|---|---|
| Pharmacy dispensing records | Very strong | Your pharmacy or pharmacy chain |
| Medical records with injection notes | Very strong | Your doctor’s office or hospital |
| Insurance claims for Depo-Provera | Strong | Your insurance provider |
| MRI/CT showing meningioma | Essential | Your medical provider or hospital |
| Surgical pathology report | Very strong | Hospital where surgery was performed |
| Personal notes or journals | Supplementary | Your own records |
Start gathering these records now, even before you contact an attorney. Medical providers can take weeks to process records requests. Having everything ready speeds up your case evaluation and filing.
One common problem: some women used Depo-Provera 15 or 20 years ago. Older records may have been destroyed. If that happens, pharmacy chains sometimes retain digital records going back further than individual doctor’s offices. Insurance companies also maintain long-term claims data.
Depo-Provera Lawsuit Deadline
The deadline to file a Depo-Provera lawsuit depends on your state’s statute of limitations for product liability or personal injury claims. There is no single national deadline, and missing your state’s cutoff means you could lose your right to file permanently.
Most states set the statute of limitations at two to three years from the date you discovered (or should have discovered) your injury. This is called the “discovery rule.” For meningioma cases, the clock typically starts when you received your diagnosis, not when you started taking Depo-Provera.
| State | Statute of Limitations | Discovery Rule |
|---|---|---|
| California | 2 years | Yes |
| Texas | 2 years | Yes |
| New York | 3 years | Yes |
| Florida | 2 years (recently changed from 4) | Yes |
| Pennsylvania | 2 years | Yes |
| Illinois | 2 years | Yes |
| Ohio | 2 years | Yes |
Some states have exceptions that can extend the deadline. These include:
- Tolling for minors (if the patient was under 18 at the time of injury)
- Fraudulent concealment (if the manufacturer actively hid the risk)
- Mental incapacity (if the patient was unable to pursue legal action due to cognitive effects of the tumor)
The safest approach is to assume your deadline is sooner than you think. Women who were diagnosed with meningioma in 2024 should be filing in 2026 at the latest, depending on their state. Do not wait until the deadline is close. Building a strong case takes time, and attorneys need months to prepare your filing.
If you are worried about timing, contact a lawyer immediately. Most firms can do a statute of limitations check within one business day.
Frequently Asked Questions
How much compensation can I get from a Depo-Provera lawsuit?
Projected settlements range from $25,000 to over $1,500,000 depending on injury severity.
Cases involving brain surgery and permanent damage are valued at the highest tier.
No settlements have been finalized yet, so amounts are estimates based on comparable pharmaceutical litigation.
What is the deadline to file a Depo-Provera lawsuit in 2026?
Deadlines vary by state, typically two to three years from the date of your meningioma diagnosis.
The discovery rule means the clock starts when you learned about the tumor, not when you used the drug.
Contact an attorney immediately to confirm your specific state’s deadline.
Do Depo-Provera lawsuit lawyers charge upfront fees?
No, virtually all Depo-Provera attorneys work on contingency.
You pay nothing unless your case results in a settlement or verdict.
Standard contingency fees range from 25% to 40% of the total recovery.
Can I file a Depo-Provera lawsuit if I no longer use the drug?
Yes, you can file even if you stopped using Depo-Provera years or decades ago.
The key requirement is a meningioma diagnosis that occurred after you received the injections.
Many current plaintiffs stopped using the drug long before their tumors were discovered.
How long does it take to settle a Depo-Provera brain tumor case?
Most mass tort settlements take two to four years from the time of filing to payout.
Bellwether trials expected in late 2026 or early 2027 will heavily influence the settlement timeline.
Individual cases may resolve faster or slower depending on their complexity and the overall litigation progress.
Take Action Now
The Depo-Provera litigation is gaining serious momentum in 2026. Women with meningioma diagnoses linked to this drug have real legal options. Bellwether trials are approaching, and the window to file is not unlimited.
Gather your medical records and usage history. Reach out to a qualified mass tort attorney for a free case evaluation. The sooner you act, the stronger your position will be.
Your health matters. Your compensation matters. Start the process today
